Donna L Senger Selected Research

Capsid Proteins (Capsid Protein)

8/2007

Proteolytic disassembly is a critical determinant for reovirus oncolysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Donna L Senger Research Topics

Disease

22	Neoplasms (Cancer) 12/2020 - 12/2003
15	Glioma (Gliomas) 12/2020 - 04/2002
13	Glioblastoma (Glioblastoma Multiforme) 10/2020 - 04/2002
9	Brain Neoplasms (Brain Tumor) 10/2020 - 12/2003
5	Infections 07/2013 - 11/2005
3	Inflammation (Inflammations) 01/2022 - 11/2010
2	Vesicular Stomatitis 01/2016 - 11/2006
2	Oligodendroglioma 09/2014 - 04/2002
1	Carcinogenesis 10/2020
1	Endotoxemia 01/2019
1	Melanoma (Melanoma, Malignant) 12/2018
1	Acute Kidney Injury (Acute Renal Failure) 01/2018
1	Alcoholism (Alcohol Abuse) 01/2016
1	Necrosis 11/2010
1	Vaccinia 04/2009
1	Rhabdoid Tumor (Rhabdoid Tumors) 02/2008
1	Neoplasm Metastasis (Metastasis) 09/2007
1	Medulloblastoma 09/2007
1	Reoviridae Infections 08/2007

Drug/Important Bio-Agent (IBA)

4	Temozolomide (Temodar)FDA LinkGeneric 01/2018 - 07/2013
4	Sirolimus (Rapamycin)FDA Link 07/2013 - 09/2007
3	Proteins (Proteins, Gene)FDA Link 11/2008 - 12/2003
2	Interleukin-33IBA 12/2020 - 10/2020
2	Peptides (Polypeptides)IBA 01/2020 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2018 - 01/2017
2	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 11/2008 - 08/2007
1	peptide AIBA 01/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 12/2020
1	eukaryotic initiation factor-5BIBA 12/2020
1	CytokinesIBA 10/2020
1	Antimitotic AgentsIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Death Domain ReceptorsIBA 12/2018
1	veliparibIBA 01/2018
1	PyrinIBA 01/2018
1	NLR ProteinsIBA 01/2018
1	Contrast MediaIBA 01/2018
1	MethyltransferasesIBA 01/2018
1	TenascinIBA 01/2017
1	Extracellular Matrix ProteinsIBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2016
1	Therapeutic UsesIBA 01/2016
1	CopperIBA 01/2016
1	Antiviral Agents (Antivirals)IBA 01/2016
1	UNC1999IBA 01/2016
1	Histone Deacetylase InhibitorsIBA 01/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016
1	Disulfiram (Antabuse)FDA Link 01/2016
1	Alkylating AgentsIBA 09/2014
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2010
1	MitogensIBA 08/2009
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2009
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2009
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 11/2008
1	Nerve Growth Factors (Neurotrophins)IBA 11/2008
1	Gamma Secretase Inhibitors and ModulatorsIBA 11/2008
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2007
1	Cathepsin BIBA 08/2007
1	Capsid Proteins (Capsid Protein)IBA 08/2007
1	Poly I-CIBA 08/2007
1	Matrix-MIBA 11/2006
1	Amino Acids FDA Link 11/2006
1	AntibodiesIBA 11/2005
1	Protein Isoforms (Isoforms)IBA 12/2003
1	Biological ProductsIBA 12/2003
1	epidermal growth factor receptor VIIIIBA 04/2002
1	MAP Kinase Kinase 1IBA 04/2002
1	ErbB Receptors (EGF Receptor)IBA 04/2002
1	GTP-Binding Proteins (G-Protein)IBA 04/2002

Therapy/Procedure

13	Therapeutics 01/2019 - 08/2007
2	Oncolytic Virotherapy 07/2013 - 09/2007
1	Computer-Assisted Surgery (Image Guided Surgery) 01/2020
1	Drug Therapy (Chemotherapy) 09/2014
1	Radiotherapy 09/2014